Medical technology company Nightingale Health Plc (HEL:HEALTH) announced on Tuesday that it has secured UKCA marking under UK Medical Devices Regulations.

This certification confirms compliance with UK medical device standards, advancing the company's efforts to bring its blood analysis technology into UK healthcare.

With a new laboratory established in Porton Science Park, South Wiltshire, Nightingale Health is positioned to expand partnerships across the UK's health ecosystem. The company has a strong track record, collaborating with top UK universities and contributing to major health initiatives like the UK Biobank.

This strategic expansion underscores Nightingale Health's commitment to enhancing preventative health in the UK.